+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Blood Screening Market Size, Share & Trends Analysis Report By Product (Reagent, Instrument), By Technology (Nucleic Acid Amplification Test, ELISA, Next Generation Sequencing), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 64 Pages
  • September 2023
  • Region: Europe
  • Grand View Research
  • ID: 4751773
Description Jump to:
The Europe blood screening market size is expected to reach USD 1, 954.8 million by 2030, registering a CAGR of 11.2% from 2023 to 2030. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the market growth.

Moreover, growth in the overall number of complex surgeries that require a large amount of blood and blood products along with rising cases of road accidents is expected to drive the market further. Additionally, import of products through contract agreements and development in the product technology by manufacturers of blood screening reagents and instruments are contributing to market expansion in the region.

For example, DiaSystem Scandinavia AB signed a distribution agreement with SNIBE, an Asian immunology test producer that focuses on immunoassay analyzers based on CLIA technology. DiaSystem specializes in the production and supply of reagents used in chemistry and immunoturbidimetry. This agreement has provided the former company with automated chemiluminescence instrument delivering a complete analytical system in areas, such as thyroid, renal function, hepatitis, and hepatic fibrosis.

Europe Blood Screening Market Report Highlights

  • NAAT led the technology segment in 2022 owing to a regulatory obligation for mandatory NAAT screening for all blood donations.
  • On the basis of product, reagents led the Europe blood screening market in 2022
  • Germany held a majority of the market share in 2022 due to large number of blood donors.
  • Moreover, stringent regulations in the country for screening of donations also contributed to its growth. The Paul-Ehrlich-Institut, a medical regulatory body in Germany, mandates NAT testing for HCV and HIV for all blood donations.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Regional scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe Blood Screening Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Europe Blood Screening Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Europe Blood Screening: Product Estimates & Trend Analysis
4.1. Europe Blood Screening Market: Key Takeaways
4.2. Europe Blood Screening Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Reagent
4.3.1. Reagent Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.4. Instrument
4.4.1. Instrument Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 5. Europe Blood Screening Market: Technology Estimates & Trend Analysis
5.1. Europe Blood Screening Market: Key Takeaways
5.2. Europe Blood Screening Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. Nucleic Acid Amplification Test
5.3.1. Nucleic Acid Amplification Test Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4. ELISA
5.4.1. ELISA Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5. Chemiluminescence Immunoassay
5.5.1. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.6. Next-Generation Sequencing
5.6.1. Next Generation Sequencing Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.7. Western Blotting
5.7.1. Western Blotting Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 6. Europe Blood Screening Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Europe Blood Screening Market by Region: Key Takeaways
6.3. Europe
6.3.1. UK
6.3.1.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. Germany
6.3.2.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. France
6.3.3.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.4. Italy
6.3.4.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.5. Spain
6.3.5.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.6. Denmark
6.3.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.7. Sweden
6.3.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.8. Norway
6.3.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Danaher Corporation
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Beckman Coulter, Inc.
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Abbott Laboratories
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Thermo Fisher Scientific, Inc.
7.2.4.1. Company Overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Becton, Dickinson and Company
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Grifols
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Ortho Clinical Diagnostics
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. F. Hoffmann-La Roche Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Bio-Rad Laboratories, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Siemens AG
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Europe blood screening market, by product, 2018 - 2030 (USD Million)
Table 3 Europe blood screening market, by technology, 2018 - 2030 (USD Million)
Table 4 Europe blood screening market, by region, 2018 - 2030 (USD Million)
Table 5 Germany blood screening market, by product, 2018 - 2030 (USD Million)
Table 6 Germany blood screening market, by technology, 2018 - 2030 (USD Million)
Table 7 UK blood screening market, by product, 2018 - 2030 (USD Million)
Table 8 UK blood screening market, by technology, 2018 - 2030 (USD Million)
Table 9 France blood screening market, by product, 2018 - 2030 (USD Million)
Table 10 France blood screening market, by technology, 2018 - 2030 (USD Million)
Table 11 Italy blood screening market, by product, 2018 - 2030 (USD Million)
Table 12 Italy blood screening market, by technology, 2018 - 2030 (USD Million)
Table 13 Spain blood screening market, by product, 2018 - 2030 (USD Million)
Table 14 Spain blood screening market, by technology, 2018 - 2030 (USD Million)
Table 15 Denmark blood screening market, by product, 2018 - 2030 (USD Million)
Table 16 Denmark blood screening market, by technology, 2018 - 2030 (USD Million)
Table 17 Sweden blood screening market, by product, 2018 - 2030 (USD Million)
Table 18 Sweden blood screening market, by technology, 2018 - 2030 (USD Million)
Table 19 Norway blood screening market, by product, 2018 - 2030 (USD Million)
Table 20 Norway blood screening market, by technology, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Europe blood screening: Market outlook
Fig. 9 Europe blood screening competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Europe blood screening market driver impact
Fig. 15 Europe blood screening market restraint impact
Fig. 16 Europe blood screening market strategic initiatives analysis
Fig. 17 Europe blood screening market: Product movement analysis
Fig. 18 Europe blood screening market: Product outlook and key takeaways
Fig. 19 Reagent market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Europe blood screening market: Technology movement analysis
Fig. 22 Europe blood screening market: Technology outlook and key takeaways
Fig. 23 Nucleic acid amplification test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Chemiluminescence Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Western blotting market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Danaher Corporation
  • Beckman Coulter, Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Grifols
  • Ortho Clinical Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Siemens AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages64
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 843.9 Million
Forecasted Market Value ( USD ) by 2030 $ 1954.8 Million
Compound Annual Growth Rate11.2%
Regions CoveredEurope
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Global Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Forecast 2024-2030 - Product Image

Global Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028 - Product Image

Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028

  • Report
  • 253 Pages
  • Global
From
Blood Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Blood Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From

About the Blood Screening Market

The Blood Screening market within the context of In Vitro Diagnostics is a rapidly growing sector of the healthcare industry. It involves the use of laboratory tests to detect and diagnose diseases and other medical conditions. These tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. Blood screening tests are used to detect the presence of antibodies, antigens, and other markers that can indicate the presence of a disease or condition. Blood screening tests are used in a variety of settings, including hospitals, clinics, and laboratories. They are also used in research and development, as well as in the development of new treatments and therapies. Blood screening tests are used to monitor the health of patients, as well as to detect and diagnose diseases and other medical conditions. Some of the major companies in the Blood Screening market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. These companies provide a wide range of products and services, including diagnostic tests, reagents, and instruments. They also offer a variety of services, such as consulting, training, and support. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.